Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-23-252528
Filing Date
2023-10-10
Accepted
2023-10-06 21:45:59
Documents
18

Document Format Files

Seq Description Document Type Size
1 S-1/A d541146ds1a.htm S-1/A 756205
2 EX-5.1 d541146dex51.htm EX-5.1 5523
3 EX-10.1 d541146dex101.htm EX-10.1 160550
4 EX-10.2 d541146dex102.htm EX-10.2 77900
5 EX-10.3 d541146dex103.htm EX-10.3 13648
6 EX-10.5 d541146dex105.htm EX-10.5 123802
7 EX-10.13 d541146dex1013.htm EX-10.13 7028
8 EX-10.21 d541146dex1021.htm EX-10.21 43672
9 EX-21.1 d541146dex211.htm EX-21.1 7642
10 EX-23.1 d541146dex231.htm EX-23.1 1555
11 EX-23.2 d541146dex232.htm EX-23.2 1552
12 EX-FILING FEES d541146dexfilingfees.htm EX-FILING FEES 30293
13 GRAPHIC g541146g0806211048287.jpg GRAPHIC 2141
14 GRAPHIC g541146g13n03.jpg GRAPHIC 595199
15 GRAPHIC g541146g13n10.jpg GRAPHIC 680365
16 GRAPHIC g541146g45k65.jpg GRAPHIC 2936
17 GRAPHIC g541146g71g71.jpg GRAPHIC 94567
18 GRAPHIC g541146g72g72.jpg GRAPHIC 90794
  Complete submission text file 0001193125-23-252528.txt   3233499
Mailing Address 221 CRESCENT STREET BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 17, SUITE 102B WALTHAM MA 02453 6176515940
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-273769 | Film No.: 231315306
SIC: 2834 Pharmaceutical Preparations